R
Radiopharm Theranostics Ltd
ASX:RAD
Radiopharm Theranostics Ltd
ASX:RAD
Price:
0.005
AUD
Market Closed
Market Cap:
AU$19.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Radiopharm Theranostics Ltd
ASX:RAD
|
AU |
|
Waraba Gold Ltd
F:ZE00
|
CA |
|
B
|
Battalion Oil Corp
F:RAQB
|
US |
|
T
|
Teixeira Duarte SA
F:TXC2
|
PT |
|
E
|
Earth Tech Environment PCL
SET:ETC
|
TH |
|
N
|
Nebius Group NV
XMUN:YDX
|
NL |
|
I
|
IP Strategy Holdings Inc
NASDAQ:IPST
|
US |
|
CleanGo Innovations Inc
F:APO
|
CA |
|
P
|
Perpetual Resources Ltd
ASX:PEC
|
AU |
|
Genmin Ltd
ASX:GEN
|
AU |
|
K
|
K&O Energy Group Inc
TSE:1663
|
JP |
Intrinsic Value
Not Available for RAD
There is not enough data to reliably calculate the intrinsic value for Radiopharm Theranostics Ltd.
Do our valuations actually work? See backtest results .
Alternatives to RAD
Fundamental Analysis
What Radiopharm Theranostics Does
Radiopharm Theranostics is a biopharmaceutical company that develops radiopharmaceutical drugs for cancer. These medicines use a radioactive component to help doctors locate tumors with imaging or deliver radiation directly to cancer cells. The company is building a pipeline of diagnostic and therapeutic products rather than selling a broad commercial drug portfolio today.
- Headquarters
- Australia AU
- Employees
- 14
- IPO date
- Nov 25, 2021
Financials
Efficiency
Earnings Waterfall
Radiopharm Theranostics Ltd
Radiopharm Theranostics Ltd
